Autoimmune diseases can raise blood pressure, and they do so more often than most people realize. The connection runs deeper than coincidence: the same inflammatory processes that drive autoimmune tissue damage also stiffen arteries, impair the kidneys’ ability to shed excess salt, and in some cases generate rogue antibodies that directly constrict blood vessels. On top of that, several medications used to treat autoimmune conditions are themselves well-known causes of hypertension. The relationship between immune dysfunction and elevated blood pressure is one of the more underappreciated intersections in medicine, with real consequences for how aggressively blood pressure should be monitored in people living with these conditions.
How Chronic Inflammation Pushes Blood Pressure Up
Blood vessels are lined with a thin layer of cells called the endothelium, which produces signals that tell the surrounding muscle to relax. The most important of these signals is nitric oxide. When chronic inflammation floods the bloodstream with immune-signaling molecules called cytokines, those cytokines interfere with nitric oxide production. The result is that blood vessels lose their ability to relax properly, stay partially constricted, and the pressure inside them rises.1Journal of Human Hypertension. Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence This is not a temporary spike. In autoimmune diseases, the inflammation is ongoing, so the endothelial damage tends to be persistent.
Two cytokines in particular stand out. Interferon-gamma and interleukin-17, both produced by overactive immune cells called T lymphocytes, drive oxidative stress and endothelial dysfunction in ways that go beyond ordinary inflammation.2PubMed Central. Role of inflammation, immunity, and oxidative stress in hypertension: New insights and potential therapeutic targets Think of oxidative stress as a kind of chemical wear-and-tear on the vessel walls. In autoimmune patients, both of these cytokines can be chronically elevated, creating a steady background force pushing blood pressure upward even when the patient feels relatively well.
When the Immune System Keeps Salt in the Body
The kidneys are the body’s main blood-pressure thermostat. When blood pressure rises, healthy kidneys respond by excreting more sodium and water, bringing the pressure back down. This safety valve depends on finely tuned salt transporters in the kidney tubules. Interleukin-17A disrupts that tuning. It reduces nitric oxide in the kidney vasculature, increases oxidative damage, promotes scarring of kidney tissue, and enhances sodium reabsorption, all of which conspire to keep blood pressure elevated.3PubMed Central. Interleukin 17A: Key Player in the Pathogenesis of Hypertension and a Potential Therapeutic Target
Animal studies have tested this directly. When mice that lack the ability to produce interferon-gamma or interleukin-17A were given a substance that normally causes hypertension, their blood pressure rose less sharply than it did in normal mice, and their kidneys maintained the ability to flush out a salt load. The normal mice lost that ability, meaning the immune cytokines had essentially jammed the kidney’s pressure-relief mechanism open on the “retain salt” setting.4PubMed Central. Renal transporter activation during angiotensin-II hypertension is blunted in interferon-γ-/- and interleukin-17A-/- mice In a person with an autoimmune disease producing excess amounts of these cytokines, the kidney faces a similar problem: the normal pressure-lowering response is blunted.
Autoantibodies That Directly Constrict Blood Vessels
Some autoimmune patients develop antibodies that don’t just attack the body’s own tissues in a general sense but specifically latch onto and activate a receptor called the angiotensin II type 1 receptor. This is the same receptor that the hormone angiotensin II uses to raise blood pressure under normal circumstances. When autoantibodies bind to it, they mimic angiotensin II, constricting blood vessels and driving blood pressure upward without any hormonal signal telling them to do so.5PubMed Central. Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond
These autoantibodies were first well-characterized in preeclampsia, a dangerous blood-pressure condition during pregnancy, but they have since been found in people with malignant hypertension who aren’t pregnant. In those patients, the antibody levels track with how severe the hypertension is, and early attempts to block or remove the antibodies have shown therapeutic promise.6PubMed. Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension This is one of the cleaner examples of autoimmunity directly causing high blood pressure: the immune system manufactures a molecule that literally squeezes the blood vessels tighter.
Specific Autoimmune Diseases and Their Blood-Pressure Patterns
Not every autoimmune disease raises blood pressure in the same way or to the same degree. Some carry especially high cardiovascular risk, and the mechanisms differ enough that they deserve separate attention.
Lupus
Systemic lupus erythematosus is one of the autoimmune diseases most consistently linked to hypertension, and kidney involvement is a major reason why. When lupus causes a specific type of kidney damage called proliferative glomerulonephritis, the odds of developing hypertension jump dramatically, with one study finding more than seven times the odds compared to lupus patients without that kidney lesion.7PubMed Central. Proliferative Glomerulonephritis: Risk Factor for Hypertension in Lupus Beyond kidney damage, lupus patients face elevated cardiovascular risk from the chronic inflammatory burden itself, and hypertension contributes to most of the heart-related illness and death in this group.8PubMed Central. Role of Inflammatory Processes in the Brain-Body Relationship Underlying Hypertension
Scleroderma
Scleroderma, or progressive systemic sclerosis, can trigger one of the most dramatic blood-pressure emergencies in medicine: scleroderma renal crisis. This event typically hits without much warning. Blood pressure spikes abruptly, kidney function deteriorates rapidly over days to weeks, and the eyes show signs of severe hypertensive damage. The underlying problem is that the kidneys’ small blood vessels become thickened and narrowed by the disease, which triggers massive release of renin, which in turn drives blood pressure even higher in a vicious cycle.9PubMed. Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis ACE inhibitors remain the first-line treatment because they interrupt this renin-driven spiral, and getting them started quickly is critical.10PubMed. Therapy of scleroderma renal crisis: State of the art
Rheumatoid Arthritis
Rheumatoid arthritis doesn’t attack the kidneys in the same direct way lupus does, but it makes arteries stiffer. Studies using pulse wave analysis have found that people with RA have increased arterial stiffness and higher central blood pressure even after accounting for traditional cardiovascular risk factors like smoking and cholesterol levels.11PubMed Central. Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis The encouraging part of this story is that the stiffness appears to be driven by current inflammation rather than permanent structural damage. In patients treated with anti-TNF-alpha therapy, aortic stiffness dropped to levels comparable to healthy individuals, suggesting that getting the inflammation under control can reverse the vascular changes.12PubMed. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy
Antiphospholipid Syndrome
Antiphospholipid syndrome, sometimes called Hughes syndrome, raises blood pressure through yet another pathway: it promotes blood clots inside the renal arteries. Among patients with APS who also had poorly controlled hypertension, about a quarter had narrowing of the renal arteries, a rate far higher than what was found in age-matched hypertensive patients without APS or in healthy controls.13PubMed Central. Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension When blood flow to a kidney is restricted, the kidney responds as if the whole body’s blood pressure is too low and pumps out signals to raise it. Anticoagulation has been the primary treatment strategy for these patients.14PubMed. Renal artery stenosis in hypertensive patients with antiphospholipid (Hughes) syndrome: outcome following anticoagulation
Autoimmune Thyroid Disease
Both overactive and underactive thyroid states can cause mild hypertension. Hyperthyroidism tends to increase the top number (systolic pressure) by revving up heart output, while hypothyroidism raises the bottom number (diastolic pressure) through increased vascular resistance. Long-standing thyroid dysfunction also promotes cholesterol abnormalities that accelerate artery-hardening, adding a structural component to the blood-pressure rise over time.15PubMed Central. Hypertension in Thyroid Disorders Because autoimmune thyroid conditions like Hashimoto’s and Graves’ disease are among the most common autoimmune disorders, this connection affects a large number of people, even if the blood-pressure increase in any individual is usually modest.
When the Treatment Itself Raises Blood Pressure
One of the more frustrating aspects of managing autoimmune disease is that several frontline treatments are themselves hypertensive. Distinguishing disease-driven hypertension from drug-driven hypertension is often the clinician’s first challenge.
Glucocorticoids like prednisone are the most common culprit. They promote sodium and water retention in the kidneys, expanding blood volume and raising pressure.16PubMed. Glucocorticoid-induced hypertension The effect is dose-dependent. A large study in children with autoimmune diseases found that high-dose oral glucocorticoids carried a sharply elevated risk of new hypertension requiring treatment, with the relative risk climbing steeply at higher doses.17Oxford Academic. Oral Glucocorticoids and Incident Treatment of Diabetes Mellitus, Hypertension, and Venous Thromboembolism in Children Adults face the same problem. For many autoimmune patients, steroids are unavoidable during flares, so the blood-pressure cost is essentially baked into the treatment plan.
Calcineurin inhibitors, particularly tacrolimus, are used in conditions like lupus nephritis and after organ transplant. These drugs increase vascular contractility, meaning they make blood vessel walls squeeze tighter in response to the same hormonal signals. Research in mice showed that tacrolimus enhanced the sensitivity of kidney and gut arteries to angiotensin II, likely through increased calcium mobilization inside smooth muscle cells.18PubMed Central. Tacrolimus Causes Hypertension by Increasing Vascular Contractility via RhoA (Ras Homolog Family Member A)/ROCK (Rho-Associated Protein Kinase) Pathway in Mice
NSAIDs, which many autoimmune patients take for pain and inflammation, block prostaglandins that normally help the kidneys excrete sodium and keep blood vessels dilated. Through sodium retention and vasoconstriction, they can nudge blood pressure upward, an effect that is especially problematic in someone whose pressure is already borderline or elevated from the disease itself.19Cardiology in Review. The Effects of Nonsteroidal Anti-Inflammatory Drugs on Blood Pressure in Hypertensive Patients
The Gut Microbiome Connection
A newer and genuinely surprising piece of this puzzle involves gut bacteria. In a lupus-prone mouse strain, the animals developed hypertension alongside their autoimmune disease. When researchers treated them with antibiotics to suppress gut bacteria, their blood pressure dropped, their endothelial function improved, and the inflammatory immune cells invading their blood vessel walls decreased. Most striking was what happened when gut bacteria from the hypertensive lupus mice were transplanted into germ-free mice: the recipient mice developed high blood pressure and vascular dysfunction even though they did not have lupus. An overgrowth of certain Bacteroides species was linked to the blood pressure increase, and neutralizing interleukin-17 blocked the effect.20PubMed. Gut microbiota contributes to the development of hypertension in a genetic mouse model of systemic lupus erythematosus
This is still early-stage research, and nobody is suggesting that lupus patients should start taking antibiotics for blood pressure. But it hints at a mechanism where the disrupted gut ecosystem in autoimmune disease may independently contribute to vascular damage, adding yet another layer to the relationship between immune dysfunction and hypertension.
Why High Blood Pressure Gets Missed in Autoimmune Patients
Given how many pathways connect autoimmunity to hypertension, you might expect aggressive blood-pressure monitoring to be standard in rheumatology clinics. In practice, it is often not. A review in Nature Reviews Cardiology highlighted evidence that hypertension is both underdiagnosed and undertreated in patients with systemic autoimmune and chronic inflammatory diseases, and recommended routine screening.21PubMed Central. Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases
Part of the problem is clinical attention. When a patient is dealing with active joint inflammation, kidney flares, or skin involvement, blood pressure can feel like a secondary concern. Another part is that hypertension in autoimmune patients tends to appear earlier in life and be more resistant to standard treatment than garden-variety high blood pressure, making it both harder to recognize as abnormal and harder to control once found. The hypertension in these patients also tends to be intertwined with fluctuating disease activity and changing medication doses, creating a moving target that requires more frequent monitoring than the average annual checkup provides.
Sex Differences and Autoimmune Hypertension
Most autoimmune diseases are more common in women. Lupus has a female-to-male ratio of roughly nine to one, and conditions like Sjögren’s disease, thyroiditis, and Graves’ disease also skew heavily female.22PubMed Central. Mechanisms underlying sex differences in autoimmunity This creates a population-level pattern where autoimmune-driven hypertension disproportionately affects women, many of whom are younger than the typical age at which clinicians start worrying about blood pressure. A 30-year-old woman with lupus who develops hypertension might have it attributed to stress or oral contraceptives rather than to the inflammatory and renal mechanisms her disease is driving.
The biological reasons for the sex skew in autoimmunity involve sex hormones, genes on the X chromosome, and hormone-driven differences in how certain immune genes are regulated. While these factors explain why women develop more autoimmune disease, they don’t appear to make the resulting hypertension less severe. If anything, the combination of autoimmune inflammation with the hormonal changes of pregnancy, perimenopause, and menopause can create particularly high-risk windows for cardiovascular complications.
Subclinical Inflammation and Lingering Vascular Risk
One of the more unsettling findings in recent research is that vascular damage can continue even when a patient’s autoimmune disease appears to be clinically inactive. A study measuring biomarkers of endothelial activation in patients with rare systemic autoimmune diseases found that a subgroup continued to show elevated markers of interferon-driven inflammation and endothelial dysfunction during periods when their disease was considered quiet by standard clinical measures.23PubMed. Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular risk
This matters because it suggests that achieving clinical remission, where the patient feels better and standard lab work looks normal, may not fully turn off the processes that damage blood vessels and raise blood pressure. The immune system may still be simmering at a level that conventional tests miss. Whether routine biomarker testing for endothelial dysfunction should become part of autoimmune disease management is an open question, but the finding reinforces a practical point: blood-pressure monitoring shouldn’t stop just because the underlying disease seems controlled.
ANCA-Associated Vasculitis and Kidney Involvement
Some autoimmune diseases attack blood vessels themselves. In ANCA-associated vasculitis, a group of conditions where the immune system targets small blood vessels throughout the body, kidney involvement is present in a majority of patients. The inflammation and tissue death in the kidneys’ tiny filtering units can lead to rapid loss of kidney function and, as the kidneys fail, rising blood pressure. A missed or delayed diagnosis of renal vasculitis can be life-threatening, because the kidney damage becomes irreversible quickly.24SpringerLink (J Nephrol). ANCA-associated vasculitis with renal involvement Unlike the gradual pressure creep seen in rheumatoid arthritis, vasculitis can cause blood pressure to escalate in weeks rather than years, making it a medical emergency rather than a chronic management issue.
For the person living with any autoimmune condition, the practical takeaway is straightforward: blood pressure deserves the same attention as the disease-specific symptoms that brought you to the doctor in the first place. If you are on steroids, calcineurin inhibitors, or regular NSAIDs, the case for monitoring is even stronger. A home blood-pressure cuff used consistently is one of the simplest things you can do to catch a problem early, especially in the weeks after a medication change or a disease flare.